This study aims to investigate the use of chemotherapy with or without bevacizumab in older patients with metastatic colorectal cancer (mCRC) in current daily practice and to identify predictive parameters for treatment-related outcomes.status: publishe
BACKGROUND: Although the efficacy and safety of combining first-line chemotherapy with bevacizumab ...
BACKGROUND: Although the efficacy and safety of combining first-line chemotherapy with bevacizumab ...
BACKGROUND: Although the efficacy and safety of combining first-line chemotherapy with bevacizumab ...
This study aims to investigate the use of chemotherapy with or without bevacizumab in older patients...
Metastatic colorectal cancer (mCRC) is mainly a disease of elderly, however, geriatric population is...
IF 7.191 (2017)International audienceBackgroundOlder patients have frailty characteristics that impa...
IF 7.191 (2017)International audienceBackgroundOlder patients have frailty characteristics that impa...
IF 7.191 (2017)International audienceBackgroundOlder patients have frailty characteristics that impa...
IF 7.191 (2017)International audienceBackgroundOlder patients have frailty characteristics that impa...
IF 7.191 (2017)International audienceBackgroundOlder patients have frailty characteristics that impa...
Background: The aim of this meta-analysis was to evaluate efficacy and safety of first-line chemothe...
Background: The aim of this meta-analysis was to evaluate efficacy and safety of first-line chemothe...
Background: The aim of this meta-analysis was to evaluate efficacy and safety of first-line chemothe...
Background: The aim of this meta-analysis was to evaluate efficacy and safety of first-line chemothe...
Background: The aim of this meta-analysis was to evaluate efficacy and safety of first-line chemothe...
BACKGROUND: Although the efficacy and safety of combining first-line chemotherapy with bevacizumab ...
BACKGROUND: Although the efficacy and safety of combining first-line chemotherapy with bevacizumab ...
BACKGROUND: Although the efficacy and safety of combining first-line chemotherapy with bevacizumab ...
This study aims to investigate the use of chemotherapy with or without bevacizumab in older patients...
Metastatic colorectal cancer (mCRC) is mainly a disease of elderly, however, geriatric population is...
IF 7.191 (2017)International audienceBackgroundOlder patients have frailty characteristics that impa...
IF 7.191 (2017)International audienceBackgroundOlder patients have frailty characteristics that impa...
IF 7.191 (2017)International audienceBackgroundOlder patients have frailty characteristics that impa...
IF 7.191 (2017)International audienceBackgroundOlder patients have frailty characteristics that impa...
IF 7.191 (2017)International audienceBackgroundOlder patients have frailty characteristics that impa...
Background: The aim of this meta-analysis was to evaluate efficacy and safety of first-line chemothe...
Background: The aim of this meta-analysis was to evaluate efficacy and safety of first-line chemothe...
Background: The aim of this meta-analysis was to evaluate efficacy and safety of first-line chemothe...
Background: The aim of this meta-analysis was to evaluate efficacy and safety of first-line chemothe...
Background: The aim of this meta-analysis was to evaluate efficacy and safety of first-line chemothe...
BACKGROUND: Although the efficacy and safety of combining first-line chemotherapy with bevacizumab ...
BACKGROUND: Although the efficacy and safety of combining first-line chemotherapy with bevacizumab ...
BACKGROUND: Although the efficacy and safety of combining first-line chemotherapy with bevacizumab ...